Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 7Recruiting 5Not yet recruiting 3Active not recruiting 3Unknown 2Terminated 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 23Thoracic 8Genitourinary 7Gynecologic 6Breast 6Lymphoid 5Head & Neck 5Sarcoma 4Dermatologic 4CNS 4Tumor-Agnostic 3Other hematologic neoplasm 3Other solid neoplasm 2Other 2Plasma cell 1Myeloid 1Endocrine 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Complete Response 1Lymphoma, T-Cell, Peripheral 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 174Rituximab 146venetoclax 82Specimen Handling 81fludarabine 80Vincristine 69obinutuzumab 68Prednisone 66Doxorubicin 66Biopsy 63Magnetic Resonance Spectroscopy 62Lenalidomide 54zanubrutinib 52Dexamethasone 48Cytarabine 44Methotrexate 43blinatumomab 41Immunotherapy, Adoptive 40acalabrutinib 37Bendamustine Hydrochloride 37fludarabine phosphate 32Etoposide 32ibrutinib 30polatuzumab vedotin 27glofitamab 27pirtobrutinib 25orelabrutinib 25Gemcitabine 24Injections 21Mercaptopurine 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Observation × Lymphoid × Clear all
NCT06249880 2026-03-09

Pediatric Normative Markerless Movement Analysis

MultiCare Health System Research Institute

Recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03516617 2026-02-09

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Mayo Clinic

Phase 2 Recruiting
120 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05633615 2026-02-02

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

SWOG Cancer Research Network

Phase 2 Recruiting
396 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07353840 2026-01-20

T-START-CR

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
160 enrolled
Lymphoid

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT06238648 2024-09-26

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Academic and Community Cancer Research United

Phase 2 Recruiting
120 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡